Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections
Authors
Keywords
-
Journal
Infectious Diseases and Therapy
Volume 10, Issue 1, Pages 115-147
Publisher
Springer Science and Business Media LLC
Online
2021-02-01
DOI
10.1007/s40121-020-00382-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non‐occlusive ST‐segment elevated myocardial infarction following the administration of liposomal amphotericin B in the treatment of cryptococcal meningitis
- (2020) Susan M. Kullab et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Antifungal drugs: What brings the future?
- (2019) Ruth Van Daele et al. MEDICAL MYCOLOGY
- Antifungal resistance in Aspergillus terreus: A current scenario
- (2019) Roya Vahedi Shahandashti et al. FUNGAL GENETICS AND BIOLOGY
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pickering emulsion stabilized by cashew gum- poly- l -lactide copolymer nanoparticles: Synthesis, characterization and amphotericin B encapsulation
- (2018) A.R. Richter et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together
- (2018) Martin Hoenigl et al. MYCOSES
- Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
- (2017) Romuald Bellmann et al. INFECTION
- Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment
- (2017) Maiken Cavling Arendrup et al. JOURNAL OF INFECTIOUS DISEASES
- Method validation and nanoparticle characterization assays for an innovative amphothericin B formulation to reach increased stability and safety in infectious diseases
- (2017) Maraine Catarina Tadini et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
- (2017) Romain Guery et al. PLoS Neglected Tropical Diseases
- Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host
- (2016) Ana C. Mesa-Arango et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients
- (2016) Silvia Park et al. JOURNAL OF INFECTION
- Comparison between liposomal formulations of amphotericin B
- (2016) Jill P Adler-Moore et al. MEDICAL MYCOLOGY
- New facets of antifungal therapy
- (2016) Ya-Lin Chang et al. Virulence
- Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
- (2015) Tihana Bicanic et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
- (2015) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles
- (2015) A.C.O. Souza et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study
- (2015) Diego R. Falci et al. MYCOSES
- Cryptococcus gattiiinfection in solid organ transplant recipients: description of Oregon outbreak cases
- (2015) G.N. Forrest et al. Transplant Infectious Disease
- Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis
- (2014) Anil A. Panackal et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Reversible dilated cardiomyopathy associated with amphotericin B therapy
- (2014) J. R. Soares et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Amphotericin forms an extramembranous and fungicidal sterol sponge
- (2014) Thomas M Anderson et al. Nature Chemical Biology
- Mechanisms of Antifungal Drug Resistance
- (2014) Leah E. Cowen et al. Cold Spring Harbor Perspectives in Medicine
- Immunoadjuvant Chemotherapy of Visceral Leishmaniasis in Hamsters Using Amphotericin B-Encapsulated Nanoemulsion Template-Based Chitosan Nanocapsules
- (2013) Shalini Asthana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure-Antifungal Activity Relationships of Polyene Antibiotics of the Amphotericin B Group
- (2013) Anna N. Tevyashova et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Insight into Amphotericin B Resistance in Aspergillus terreus
- (2013) Gerhard Blum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Candida albicans biofilms: building a heterogeneous, drug-tolerant environment
- (2013) Julie Bonhomme et al. CURRENT OPINION IN MICROBIOLOGY
- Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex
- (2013) Rolin L. Wade et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- Combination antifungal therapy for invasive fungal infections in children and adults
- (2013) Nevin Hatipoglu et al. Expert Review of Anti-Infective Therapy
- Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant
- (2012) Xiaojun Huang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (FungisomeTM) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India
- (2012) MP Jadhav et al. INDIAN JOURNAL OF CANCER
- Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children
- (2012) Keisuke Sunakawa et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Amphotericin primarily kills yeast by simply binding ergosterol
- (2012) K. C. Gray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst
- (2011) Fernanda Sangalli-Leite et al. MICROBES AND INFECTION
- Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities
- (2011) D. S. Palacios et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antifungal PK/PD Considerations in Fungal Pulmonary Infections
- (2011) Alexander Lepak et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Lipsosomal Amphotericin B for Treatment of Cutaneous Leishmaniasis
- (2010) Glenn Wortmann et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
- (2010) J. R. Wingard et al. BLOOD
- Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?
- (2010) Coralia N. Mihu et al. CANCER
- Continuous Infusion of Amphotericin B Deoxycholate in the Treatment of Cryptococcal Meningoencephalitis: Analysis of Safety and Fungicidal Activity
- (2010) Diego Rodrigues Falci et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
- (2010) John R. Perfect et al. CLINICAL INFECTIOUS DISEASES
- Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: A prospective, randomized, open-label, placebo-controlled pilot study
- (2010) Antonio C. Arrieta et al. CLINICAL THERAPEUTICS
- Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica
- (2010) M. Solomon et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs
- (2010) Yong-Qiang Zhang et al. PLoS Pathogens
- A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV‐Associated Cryptococcal Meningitis
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
- (2009) Catherine Cordonnier et al. CLINICAL INFECTIOUS DISEASES
- Our Current Understanding of Fungal Biofilms
- (2009) Gordon Ramage et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics
- (2009) Suk Hyun Jung et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex
- (2009) Charles Craddock et al. Expert Opinion On Drug Safety
- Apoptosis in Candida biofilms exposed to amphotericin B
- (2009) R. S. Al-Dhaheri et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Potential Basis for Amphotericin B Resistance in Aspergillus terreus
- (2008) G. Blum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and In Vitro Biological Properties of Novel Cationic Derivatives of Amphotericin B
- (2008) Valérie Paquet et al. CHEMISTRY-A EUROPEAN JOURNAL
- Immunocompromised Hosts: Immunopharmacology of Modern Antifungals
- (2008) R. Ben‐Ami et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started